论文部分内容阅读
目的探讨卡维地洛治疗慢性充血性心力衰竭患者的疗效。方法将160例CHF患者随机分为观察组(80例)、对照组(80例)。两组患者均采用常规抗CHF治疗,观察组在此基础上加用卡维地洛片。结果观察组患者治疗后的总有效率、血压与心率改善情况均明显优于对照组,差异均存在统计学意义(P<0.05)。观察组有2例患者发生窦性心动过缓、2例出现轻度头晕,血压正常,减量后症状消失。结论 CHF患者采用常规抗CHF联合卡维地洛治疗,其疗效好、耐受性好、无严重不良反应,可有效改善心功能,提高生存率。
Objective To investigate the efficacy of carvedilol in patients with chronic congestive heart failure. Methods 160 CHF patients were randomly divided into observation group (80 cases) and control group (80 cases). The two groups of patients were treated with conventional anti-CHF, the observation group on this basis with the use of carvedilol tablets. Results The total effective rate, the improvement of blood pressure and heart rate in the observation group were significantly better than those in the control group, the differences were statistically significant (P <0.05). In the observation group, sinus bradycardia occurred in 2 patients, mild dizziness in 2 patients, normal blood pressure, and the symptoms disappeared after reduction. Conclusion CHF patients with conventional anti-CHF combined with carvedilol treatment, the effect is good, well tolerated, no serious adverse reactions, which can effectively improve cardiac function and improve survival.